Pfizer Inc.
PFE
Classificação em ações
#119
Pfizer Inc. is a global biopharmaceutical leader engaged in the research,... Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small molecule drugs, immunotherapies, and biosimilars for various conditions, exemplified by Ibrance, Xtandi, and Retacrit. Furthermore, Pfizer provides sterile injectables, anti-infective agents, and a significant oral treatment for COVID-19, including Paxlovid. A substantial portion of its offerings comprises vaccines for infectious diseases such as pneumococcal and meningococcal disease, tick-borne encephalitis, and COVID-19, with notable products like Comirnaty and the Prevnar family. The firm also develops biosimilars for chronic autoimmune and inflammatory disorders, including Inflectra and Xeljanz, alongside specialized therapies for rare conditions like amyloidosis, hemophilia, and endocrine disorders, under brands such as Vyndaqel and BeneFIX. Beyond its proprietary products, Pfizer operates a contract manufacturing division. Its extensive customer base includes wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual medical practices, and public health organizations. The company actively fosters strategic collaborations with numerous partners, such as Bristol-Myers Squibb Company, BioNTech SE, and Merck KGaA. Established in 1849, Pfizer Inc. is headquartered in New York, New York.
Preço da ação
$29.47
Última sincronização: 2026-10-19
Valor de mercado
$167.94B
Variação (1 dia)
-0.27%
Variação (1 ano)
19.34%
País
US
Negociar Pfizer Inc. (PFE)
Categoria
Healthcare
Lucros da Pfizer Inc. (PFE)
Lucros em Jun 2026 TTM: $4.21B
De acordo com os últimos relatórios financeiros da Pfizer Inc., os ganhos atuais da empresa são de $4.21B. Em 2024, a empresa teve ganhos de $8.02B, um aumento em relação a aos ganhos de 2023, que foram de $1.06B. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Pfizer Inc. de 2000 a 2026
Lucros no final de cada ano
| Ano | Lucros | Alterar |
|---|---|---|
| 2026 (TTM) | $4.21B | -44.03% |
| 2025 | $7.52B | -6.27% |
| 2024 | $8.02B | 658.32% |
| 2023 | $1.06B | -96.95% |
| 2022 | $34.73B | 42.85% |
| 2021 | $24.31B | 245.52% |
| 2020 | $7.04B | -38.74% |
| 2019 | $11.49B | -3.37% |
| 2018 | $11.89B | -3.41% |
| 2017 | $12.31B | 47.35% |
| 2016 | $8.35B | -6.85% |
| 2015 | $8.97B | -26.76% |
| 2014 | $12.24B | -22.12% |
| 2013 | $15.72B | 39.80% |
| 2012 | $11.24B | -2.08% |
| 2011 | $11.48B | 23.69% |
| 2010 | $9.28B | -14.27% |
| 2009 | $10.83B | 11.69% |
| 2008 | $9.69B | 4.48% |
| 2007 | $9.28B | -28.78% |
| 2006 | $13.03B | 20.63% |
| 2005 | $10.80B | -22.90% |
| 2004 | $14.01B | 329.27% |
| 2003 | $3.26B | -72.34% |
| 2002 | $11.80B | 14.20% |
| 2001 | $10.33B | 79.11% |
| 2000 | $5.77B | 0.00% |
Lucros de empresas semelhantes ou concorrentes
| Empresa | Lucros | Diferença de Lucros | País |
|---|---|---|---|
| $33.60B | 698.18% |
US
|
|
| $17.74B | 321.41% |
US
|
|
| $8.70B | 106.68% |
US
|
|
| $5.95B | 41.32% |
US
|
|
| $21.39B | 408.16% |
CH
|
